Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Wiestner

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|August 19, 2007
Prognostic factors for risk-adapted therapy in chronic lymphocytic leukemia - the search continuesYair Herishanu, Adrian Wiestner
Leukemia & Lymphoma|December 24, 2015
Under the microscope: CCL3 and T cells in the microenvironment of chronic lymphocytic leukemiaClare Sun, Adrian Wiestner
Hematology/Oncology Clinics of North America|June 27, 2021
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?Clare Sun, Adrian Wiestner
Cancer Treatment and Research|February 7, 2015
Prognosis and therapy of chronic lymphocytic leukemia and small lymphocytic lymphomaClare Sun, Adrian Wiestner
Seminars in Hematology|July 23, 2014
Chronic lymphocytic leukemia: moving forward-rapidlyJennifer R Brown, Adrian Wiestner
Seminars in Cancer Biology|September 25, 2013
B-cell receptor signaling as a driver of lymphoma development and evolutionCarsten U Niemann, Adrian Wiestner
Nature Reviews. Cancer|January 20, 2018
Targeting B cell receptor signalling in cancer: preclinical and clinical advancesJan A Burger, Adrian Wiestner
Seminars in Hematology|October 29, 2003
Towards molecular diagnosis and targeted therapy of lymphoid malignanciesAdrian Wiestner, Louis M Staudt
Seminars in Hematology|July 26, 2011
Molecular targeted approaches in mantle cell lymphomaMarc A Weniger, Adrian Wiestner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-ReplySarah E M Herman, Adrian Wiestner
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|August 19, 2007
Prognostic factors for risk-adapted therapy in chronic lymphocytic leukemia - the search continuesYair Herishanu, Adrian Wiestner
Leukemia & Lymphoma|December 24, 2015
Under the microscope: CCL3 and T cells in the microenvironment of chronic lymphocytic leukemiaClare Sun, Adrian Wiestner
Hematology/Oncology Clinics of North America|June 27, 2021
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?Clare Sun, Adrian Wiestner
Cancer Treatment and Research|February 7, 2015
Prognosis and therapy of chronic lymphocytic leukemia and small lymphocytic lymphomaClare Sun, Adrian Wiestner
Seminars in Hematology|July 23, 2014
Chronic lymphocytic leukemia: moving forward-rapidlyJennifer R Brown, Adrian Wiestner
Seminars in Cancer Biology|September 25, 2013
B-cell receptor signaling as a driver of lymphoma development and evolutionCarsten U Niemann, Adrian Wiestner
Nature Reviews. Cancer|January 20, 2018
Targeting B cell receptor signalling in cancer: preclinical and clinical advancesJan A Burger, Adrian Wiestner
Seminars in Hematology|October 29, 2003
Towards molecular diagnosis and targeted therapy of lymphoid malignanciesAdrian Wiestner, Louis M Staudt
Seminars in Hematology|July 26, 2011
Molecular targeted approaches in mantle cell lymphomaMarc A Weniger, Adrian Wiestner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-ReplySarah E M Herman, Adrian Wiestner
Pageof 19